Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Inks Assay Deal with Korean University

NEW YORK (GenomeWeb News) – PerkinElmer today said that it has entered into a drug discovery research collaboration with Sangmyung University in Korea, which will use the firm's AequoScreen assay technology for G-protein coupled receptor research.

PerkinElmer said that the AequoScreen cell-based assays are used to detect GPCR activation and provide advantages over conventional fluorescence-based dyes, such as fewer false positives, simpler protocol, and increased assay windows.

The firm said that Sangmyung will use the assays as part of its efforts to establish an academic GPCR screening facility in collaboration with Korea Chemical Bank, which has a repository library of more than 100,000 small molecule compounds. The assays will be used as part of nationwide GPCR screening campaigns and drug discovery programs, said PerkinElmer.

Financial terms of the alliance were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.